REGN727

DRUG2 trials

Sponsors

Regeneron Pharmaceuticals

Conditions

HealthyHealthy Volunteers

Phase 1

Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers

CompletedNCT01026597

Regeneron PharmaceuticalsHealthy

Start: 2009-11-30End: 2010-10-31Updated: 2015-01-27

Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers

CompletedNCT01074372

Regeneron PharmaceuticalsHealthy Volunteers

Start: 2010-03-31End: 2010-11-30Updated: 2015-01-27

Related Papers

Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

2012-03-01497 citations